Core Insights - Outset Medical, Inc. reported unaudited revenue for Q4 and fiscal year 2025, highlighting a 5% increase in annual revenue to approximately $119.5 million compared to $113.7 million in 2024 [8] - The company has appointed Karen N. Prange to its board of directors, bringing extensive experience in commercial operations and strategy [4][5][6] - Outset Medical aims to leverage its innovative technology to enhance patient care outcomes while reducing costs and complexity in dialysis [3] Financial Performance - Q4 revenue reached approximately $28.9 million, contributing to the total revenue of approximately $119.5 million for 2025 [8] - The year-end cash position, including restricted cash and short-term investments, totaled $173 million, with net cash used in operations below $50 million in 2025, a significant decrease from $116 million in 2024 [8] Company Developments - Outset Medical has established a strong backlog and a growing pipeline of opportunities as it enters 2026 [3] - The company has enabled over 1,000 care sites to insource dialysis, performing roughly 1 million treatments annually, with a cumulative total of over 3 million treatments on its Tablo system [8] - The appointment of Karen Prange is expected to enhance the board's capabilities in navigating growth opportunities in the acute-care setting [6]

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp., as sole bookrunner and co-lead underwriter, on behalf of a syndicate of underwriters, which includes BMO Capital Markets as co-lead underwriter (collectively, the "Underwriters ...

Company Overview - Outset Medical, Inc. is a medical technology company focused on transforming the dialysis experience with innovative technology [3] - The company’s flagship product, the Tablo® Hemodialysis System, is FDA-cleared for use in various settings, from hospitals to home care [3] - Tablo integrates water purification and on-demand dialysate production into a single system, enhancing operational efficiency and patient care [3] Key Presentation Details - Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on January 14, 2026, at 4:30 p.m. Pacific time [1] - A live and archived webcast of the presentation will be available on the Outset Medical website [2] Market Impact - The Tablo system is currently trusted by over 1,000 healthcare facilities in the U.S. and has facilitated millions of treatments by thousands of nurses [3] - Outset Medical aims to empower healthcare providers to establish in-house dialysis programs, leading to improved operational, clinical, and financial outcomes [3]

Core Viewpoint - Osisko Metals Incorporated has appointed Jeff Hussey as Chief Operating Officer, effective immediately, to advance its Gaspé Copper Project [1][4]. Company Overview - Osisko Metals is a Canadian exploration and development company focused on critical metals, particularly copper and zinc [4]. - The company acquired a 100% interest in the Gaspé Copper mine from Glencore Canada Corporation in July 2023, which is located in Québec's Gaspé Peninsula [4]. - The Gaspé Copper mine hosts the largest undeveloped copper resource in eastern North America, with current Indicated Mineral Resources of 824 million tonnes averaging 0.34% CuEq and Inferred Mineral Resources of 670 million tonnes averaging 0.38% CuEq [4]. Leadership Changes - Jeff Hussey has over 40 years of experience in the exploration and mining industries and has held various management positions within Osisko Metals, including CEO of Pine Point Mining Limited [2][3]. - He has resigned from the board of directors of Osisko Metals but will continue to support Pine Point Mining Limited while focusing on the Gaspé Copper project as COO [3]. Project Details - The Gaspé Copper project is currently focused on resource expansion and is undergoing economic evaluation, permitting, and startup phases [3]. - In addition to the Gaspé Copper project, Osisko Metals is advancing the Pine Point project, which has Indicated Mineral Resources of 49.5 million tonnes averaging 5.52% ZnEq and Inferred Mineral Resources of 8.3 million tonnes averaging 5.64% ZnEq [5].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices by Outset Medical and its officers/directors, following disappointing financial results and a significant drop in stock price [1][3]. Financial Performance - On November 10, 2025, Outset Medical reported non-GAAP earnings per share of -$0.69, missing consensus estimates by $0.03 [3]. - The company generated revenue of $29.43 million for the third quarter of 2025, which was $1.27 million below consensus estimates [3]. - Outset Medical revised its 2025 revenue outlook to a range of $115 million to $120 million, down from a previous range of $122 million to $126 million, citing delays in closing large opportunities [3]. Stock Market Reaction - Following the announcement of the financial results, Outset Medical's stock price fell by $5.85 per share, or 48.47%, closing at $6.22 per share on November 11, 2025 [3].

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce that it has completed its previously announced non-brokered private placement with four strategic investors, pursuant to which the Company issued an aggregate of 67,666,666 common shares of the Company (the "Common Shares") at an offering price ...

Core Viewpoint - Osisko Metals is set to receive a C$32.5 million ($23.2 million) investment to support the development of its Gaspé copper project in Quebec, with participation from several prominent mining companies [1][2]. Investment Details - Osisko will issue approximately 67.66 million common shares at a price of C$0.48 each through a private placement [2]. - Notable participants include Hudbay Minerals, Agnico Eagle Mines, and Franco-Nevada, with Hudbay expected to acquire over 29 million shares, representing 4.3% of outstanding shares post-financing [3]. Market Reaction - Following the announcement, Osisko Metals' stock surged over 12% to a near 52-week high of C$0.55, resulting in a market capitalization of approximately C$330.7 million ($237.1 million) [4]. Project Overview - The funding will advance the Gaspé copper project, touted as the largest copper project in eastern North America, with planned activities including drilling, permitting, and technical studies [5]. - The Gaspé mine, located near Murdochville, is expected to start producing around 500,000 tonnes of copper concentrate annually by 2032, supported by federal and provincial backing [6]. Resource Assessment - Currently, the Gaspé project has 824 million indicated tonnes grading 0.27% copper, equating to 2.23 million tonnes of contained copper, and an additional 670 million tonnes inferred grading 0.3% copper, totaling 1.99 million tonnes of copper [7].

Core Viewpoint - Osisko Metals Incorporated is set to complete a non-brokered private placement of approximately 67,666,666 common shares at an offering price of $0.48 per share, aiming for gross proceeds of about $32,480,000 to advance its Gaspé Copper project [1][4]. Group 1: Private Placement Details - The private placement will include subscriptions from strategic investors, with the size depending on contractual participation rights granted to Glencore Canada Corporation [2]. - Hudbay Minerals is expected to acquire 29,166,666 common shares, representing approximately 4.3% of the issued shares, while Agnico Eagle Mines is expected to own 87,815,000 shares, equating to about 12.5% ownership [3]. - The net proceeds from the private placement will be utilized for advancing the Gaspé Copper project, including drilling, permitting, and technical studies [4]. Group 2: Strategic Partnerships and Shareholder Support - The participation of Hudbay Minerals as a significant shareholder is viewed as a positive endorsement of the Gaspé Copper project's potential [3]. - An investor rights agreement will be established between the company and Hudbay, granting Hudbay certain rights, including top-up rights and future participation in offerings [3]. Group 3: Company Overview and Project Focus - Osisko Metals is focused on the critical metals sector, particularly copper and zinc, and has a 100% interest in the Gaspé Copper project, which is the largest undeveloped copper resource in eastern North America [6][8]. - The Gaspé Copper project has current indicated mineral resources of 824 million tonnes at a grade of 0.34% CuEq and inferred resources of 670 million tonnes at 0.38% CuEq [6]. - The company is also advancing the Pine Point project, which has indicated mineral resources of 49.5 million tonnes at 5.52% ZnEq [9].

Company Overview - Outset Medical Inc. is a medical technology company based in San Jose, California, known for developing and producing the Tablo Hemodialysis System [3]. Allegations and Financial Performance - On November 10, 2025, Outset Medical reported its third-quarter 2025 financial results, showing non-GAAP earnings per share of –$0.69, which missed consensus estimates by $0.03. The revenue was reported at $29.43 million, falling short of expectations by $1.27 million [4]. - The company also revised its full-year 2025 revenue guidance down to a range of $115–$120 million from the previous range of $122–$126 million, citing delays in several anticipated opportunities [4]. Stock Market Reaction - Following the financial announcement, Outset Medical's stock price dropped by $5.85 per share, or 48.47%, closing at $6.22 per share on November 11, 2025 [5].

Core Insights - Osisko Metals has announced new drill results from the Gaspé Copper Project, confirming significant higher-grade mineralization, particularly in the southern extension, with drill hole 30-1136 returning 64.5 metres averaging 2.70% Cu [2][6] - The company is optimistic about the growth of the project and anticipates an updated Mineral Resource Estimate (MRE) in early 2026 [2][27] Drill Results Summary - Drill hole 30-1136 reported 284.5 metres averaging 0.41% Cu, including a high-grade interval of 64.5 metres averaging 2.70% Cu [6][12] - Drill hole 30-1120 showed 598.5 metres averaging 0.28% Cu, contributing to infill and expansion efforts [6][8] - Drill hole 30-1129 revealed 881.0 metres averaging 0.22% Cu, with significant mineralization extending to a vertical depth of 897.9 metres [6][9] - Drill hole 30-1133 indicated 550.5 metres averaging 0.28% Cu, confirming mineralization to a depth of 831 metres [6][10] - Drill hole 30-1134 demonstrated 309.0 metres averaging 0.17% Cu and a deeper intersection of 228.5 metres averaging 0.41% Cu [6][11] - Drill hole 30-1138 confirmed mineralization with 685.8 metres averaging 0.27% Cu [6][13] - Drill hole 30-1139 showed 873.0 metres averaging 0.23% Cu, confirming mineralization to a depth of 815 metres [6][14] - Drill hole 30-1140 reported five intersections of mineralization, including 105.0 metres averaging 0.43% Cu [6][15] Project Overview - The Gaspé Copper Project is characterized by porphyry copper/skarn type mineralization, with significant historical mining potential [16][27] - The current drill program aims to convert the November 2024 MRE to Measured and Indicated categories and explore deeper and lateral expansions of the mineralization [18][27] - Osisko Metals acquired a 100% interest in the Gaspé Copper mine in July 2023, which hosts the largest undeveloped copper resource in eastern North America [27][28]